May 14th 2024
In a comparison of pediatric dermatologists versus AI, dermatologists primarily exhibited greater performance.
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Derms Reflect on Cosmetics Impact
February 1st 2003The image of dermatology as a medical profession has undergone a variety of changes over the decades. In the 1800s and the early part of the 20th century, dermatologists were the physicians to go to for venereal diseases, as well as diseases of the skin, so their place as a medical necessity was secure.
Innovate, integrate, and treat
January 1st 2003Las Vegas - Much of what is new in dermatologic therapy represents off-label use of marketed drugs, but clinicians should not let that fact necessarily deter them from prescribing what may be very safe and effective therapy, said Stephen Stone, M.D., at the Fall Clinical Dermatology Conference.
Psychology of psoriasis keys compliance
January 1st 2003New York - For treatment of localized psoriasis, breaking down the barriers to compliance can begin with something as simple as the human touch, according to Steven R. Feldman, M.D., Ph.D., director, Psoriasis Treatment Center, Wake Forest University School of Medicine, Winston-Salem, N.C.
Management beyond corticosteriods starts with assessing risk to skin, reducing sun exposure
January 1st 2003Paris - Treatment for dermatomyositis (DM) begins with sun avoidance and sun-protective measures, Jeffrey P. Callen, M.D., said at the World Congress of Dermatology. "The first line of therapy is to recognize that the patient is photosensitive."
Is Parental Consent Valid for Minor Children?
December 15th 2002Anew oral retinoid has been FDA cleared for the treatment of psoriasis. It has been shown to be safer than all previously available retinoids. Dr. Doe learned that this medication has been used safely in Europe for the prevention of acne in pre-adolescent teenagers. He has a large adolescent practice and is excited about using this medication on his young patients. Recognizing that the drug does not have FDA clearance for his intended use, he asks parents of prospective patients to sign a consent form allowing him to use this potentially miraculous drug on their children. Is the consent of the parent valid?
Mole-atopic dermatitis relationship reversed in children
October 1st 2002Los Angeles - Among 3-year-olds, children with atopic dermatitis have significantly more melanocytic nevi than their unaffected counterparts, and the difference in nevi count overall can be accounted for by higher numbers of nevi present in light-skinned children with eczema, Robert Dellavalle, M.D., Ph.D., said at the annual meeting of the Society for Investigative Dermatology.
Tacrolimus ointment tackles signs of seborrheic dermatitis
October 1st 2002Paris - Results from a small pilot study suggest that topical tacrolimus ointment 0.1 percent (Protopic) may be a promising new treatment for seborrheic dermatitis, researchers from Emory University School of Medicine, Atlanta, reported.
Skin substitutes valuable for hard-to-heal wounds
September 15th 2002Paris - Bioengineered skin substitutes can facilitate healing of difficult wounds and even achieve closure of some long-standing chronic wounds refractory to other measures, but the success of these modalities depends on proper wound bed preparation and even then, they may not be the answer for all patients, Vincent Falanga, M.D., said at the World Congress of Dermatology.